General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The growth in unit sales is primarily driven by the increase in the mechanical thrombectomy market. Innovation in the treatment of ischemic stroke with new technology like stent retrievers and flow diverting stents, which require guidewires as well, will drive an increase in the number of guidewires required as well. Approximately 1.3 to 1.4 guidewires are used for each coiling procedure. There may be a decrease in coiling procedures over the forecast period as flow diverters and other new technologies cannibalize market share but since guidewires will be used with all of these new technologies as well it should not limit the market. Since the mechanical thrombectomy market is experience high growth there should be high single unit digit growth in the guidewire market over the forecast period.
Germany is the most penetrated market in terms of mechanical thrombectomy in Europe so a higher rate of market growth will likely be seen there. Germany is also the largest market for stent placement and detachable coil procedures so the growth in these markets will also drive the guidewire market in Germany.
There has been an increase in the number of procedures as well as more complicated procedures being performed; as a result, the number of guidewires used per procedure has increased, driving the unit sales. Guidewires have enhanced distal navigation and trackability properties that have allowed for the guidewire of choice to be used in various complex neurological procedures. Some more complex procedures require closer to 1.7 to 1.8 guidewires per procedure. There is also some conversion to more advanced and high torque wires, which command a higher ASP.
'
TABLE OF CONTENTS I
LIST OF FIGURES IX
LIST OF CHARTS XI
EXECUTIVE SUMMARY 1
EUROPEAN NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 7
MARKET DEVELOPMENTS 10
MARKETS INCLUDED 11
PROCEDURES INCLUDED 12
KEY REPORT UPDATES 13
VERSION HISTORY 13
RESEARCH METHODOLOGY 14
1.1 RESEARCH SCOPE 14
1.2 IDATA’S 9-STEP METHODOLOGY 14
Step 1: Project Initiation & Team Selection 14
Step 2: Prepare Data Systems and Perform Secondary Research 16
Step 3: Preparation for Interviews & Questionnaire Design 17
Step 4: Performing Primary Research 18
Step 5: Research Analysis: Establishing Baseline Estimates 20
Step 6: Market Forecast and Analysis 21
Step 7: Identify Strategic Opportunities 23
Step 8: Final Review and Market Release 24
Step 9: Customer Feedback and Market Monitoring 25
DISEASE OVERVIEW 26
2.1 BASIC ANATOMY 26
2.2 DISEASE PATHOLOGY AND DISORDERS 28
2.2.1 Introduction 28
2.2.2 General Diagnostics and Neurosurgery 30
2.2.3 Tumor and Brain Cancer 32
2.2.4 Brain Arteriovenous Malformations 34
2.2.5 Ischemic Stroke 35
2.2.6 Brain Aneurysm 36
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure 38
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder 38
2.2.7.2 Cerebral Edema 39
2.2.8 Indication for Neuromodulation 41
2.2.9 Traumatic brain injury 43
COUNTRY PROFILES 44
3.1 INTRODUCTION 44
3.1.1 Population 44
3.1.2 GDP Per Capita 44
3.1.3 Price Index 44
3.2 GERMANY 45
3.3 FRANCE 46
3.4 UNITED KINGDOM 47
3.5 ITALY 48
3.6 SPAIN 49
3.7 BENELUX 50
3.8 SCANDINAVIA 51
3.9 AUSTRIA 52
3.10 SWITZERLAND 53
3.11 PORTUGAL 54
PRODUCT ASSESSMENT 55
4.1 PRODUCT PORTFOLIOS 55
4.1.1 Neurovascular Guidewires 55
4.1.1.1 Introduction 55
4.1.1.2 Product Matrix for Neurovascular Guidewires Market: Core Companies 57
4.2 REGULATORY ISSUES AND RECALLS 58
4.2.1 Neurovascular Guidewires 58
NEUROVASCULAR GUIDEWIRE MARKET 59
5.1 INTRODUCTION 59
5.2 MARKET ANALYSIS AND FORECAST 60
5.3 DRIVERS AND LIMITERS 67
5.3.1 Market Drivers 67
5.3.2 Market Limiters 67
5.4 COMPETITIVE MARKET SHARE ANALYSIS: 69
ABBREVIATIONS 74
APPENDIX: COMPANY PRESS RELEASES 77
Chart 1 1: Neurological Device Market by Segment, Europe, 2013 – 2023 2
Chart 1 2: Neurological Device Market Overview, Europe, 2013 &2023 2
Chart 3 1: Country Profile, Germany, 2016 45
Chart 3 2: Country Profile, France, 2016 46
Chart 3 3: Country Profile, United Kingdom, 2016 47
Chart 3 4: Country Profile, Italy, 2016 48
Chart 3 5: Country Profile, Spain, 2016 49
Chart 3 6: Country Profile, Benelux, 2016 50
Chart 3 7: Country Profile, Scandinavia, 2016 51
Chart 3 8: Country Profile, Austria, 2016 52
Chart 3 9: Country Profile, Switzerland, 2016 53
Chart 3 10: Country Profile, Portugal, 2016 54
Chart 5 1: Neurovascular Guidewire Market, Europe, 2013 – 2023 61
Chart 5 2: Leading Competitors, Neurovascular Guidewire Market, Europe, 2016 73
Figure 1 1: Neurological Device Market Share Ranking by Segment, Europe, 2016 (1 of 3) 4
Figure 1 2: Neurological Device Market Share Ranking by Segment, Europe, 2016 (2 of 3) 4
Figure 1 3: Neurological Device Market Share Ranking by Segment, Europe, 2016 (3 of 3) 5
Figure 1 4: Companies Researched in this Report, Europe, 2016 6
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, Europe (1 of 3) 7
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, Europe (2 of 3) 8
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, Europe (3 of 3) 9
Figure 1 8: Recent Events in the Neurological Device Market, Europe, 2014 – 2016 10
Figure 1 9: Neurological Device Markets Covered, Europe, 2016 11
Figure 1 10: Neurological Device Procedures Covered, Europe, 2016 12
Figure 1 11: Key Report Updates 13
Figure 1 12: Version History 13
Figure 2 1: Neurology Disease Overview 29
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016 33
Figure 4 1: Class 1 Device Recall: THUNDER Steerable Guidewire 58
Figure 4 2: Class 2 Device Recall: Fathom"14 Steerable Guidewire Peripheral Vascular Use, 200 cm x 10 cm 58
Figure 5 1: Neurovascular Guidewire Market, Europe, 2013 – 2023 (€ and US$) 61
Figure 5 2: Units Sold by Country, Neurovascular Guidewire Market, Europe, 2013 – 2023 62
Figure 5 3: Average Selling Price by Country, Neurovascular Guidewire Market, Europe, 2013 – 2023 (€) 63
Figure 5 4: Average Selling Price by Country, Neurovascular Guidewire Market, Europe, 2013 – 2023 (US$) 64
Figure 5 5: Market Value by Country, Neurovascular Guidewire Market, Europe, 2013 – 2023 (€M) 65
Figure 5 6: Market Value by Country, Neurovascular Guidewire Market, Europe, 2013 – 2023 (US$M) 66
Figure 5 7: Drivers and Limiters, Neurovascular Guidewire Market, Europe, 2016 68
Figure 5 8: Leading Competitors, Neurovascular Guidewire Market, Europe, 2016 72
Figure 7 1: Press Release Summary 77
Medtronic
Stryker
Codman & Shurtleff, Inc.
St. Jude Medical
Nevro
Carl Zeiss
Boston Scientific
LivaNova
Terumo MicroVention
Penumbra Inc.
Leica
Integra LifeSciences
BrainLab
Balt
Magstim
Phenox
MagVenture
Elekta
Moëller Wedel
Misonix
Sophysa
Aesculap
MAG & More
Neurosoft
Acandis
Soring
Brainsway
Nexstim
Others include: ANT, Asahi Intecc, Axonics, Blockade, Dispomedica, Enteromedics, Flowonix, Inomed, Intrapace, Kaneka Medical Products, MHT, Micrus Endovascular, MRC, Navimetric, Neuravi, Neuronetics, Neuropace, NextGen Medicla System, Nuvectra, Scientia Vascular, Spiegelberg, Stimwave, Tokai Medical Product, Tricumed, Vascular Solutions, etc.
